Latest filing published 11 Aug 2026 for Rhythm Pharmaceuticals, INC., €1.1M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Pamela Cramer: trading record in brief
Pamela Cramer discloses dealings in Rhythm Pharmaceuticals, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 10 August 2026 to 11 August 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 11 August 2026 came the latest disclosure, a transaction for €1.1M in Rhythm Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Pamela Cramer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,406 shares@ US$115.48CommonSEC144:0001950047-26-007962
- 3,520 shares@ US$115.63100.0% of flowCommonSEC144:0001950047-26-007889
2 of 2 declarations
